166 related articles for article (PubMed ID: 32757401)
1. Bone lesions in hairy cell leukemia: Diagnosis and treatment.
Robak P; Jesionek-Kupnicka D; Kupnicki P; Polliack A; Robak T
Eur J Haematol; 2020 Dec; 105(6):682-691. PubMed ID: 32757401
[TBL] [Abstract][Full Text] [Related]
2. Skeletal complications in hairy cell leukemia: diagnosis and therapy.
Lembersky BC; Ratain MJ; Golomb HM
J Clin Oncol; 1988 Aug; 6(8):1280-4. PubMed ID: 3411340
[TBL] [Abstract][Full Text] [Related]
3. Skin changes in hairy cell leukemia.
Robak E; Jesionek-Kupnicka D; Robak T
Ann Hematol; 2021 Mar; 100(3):615-625. PubMed ID: 33216198
[TBL] [Abstract][Full Text] [Related]
4. [Bone lesions in hairy cell leukaemia (author's transl)].
Weh HJ; Katz M; Bray B; Rodat O; Degos L; Flandrin G
Nouv Presse Med; 1979 Jun; 8(27):2253-4. PubMed ID: 492998
[TBL] [Abstract][Full Text] [Related]
5. Clinical problems in hairy cell leukemia: diagnosis and management.
Westbrook CA; Golde DW
Semin Oncol; 1984 Dec; 11(4 Suppl 2):514-22. PubMed ID: 6390685
[TBL] [Abstract][Full Text] [Related]
6. Localized bone disease as a presentation of hairy cell leukemia.
Karmali R; Farhat M; Leslie W; McIntire MG; Gregory S
Clin Adv Hematol Oncol; 2008 Apr; 6(4):290-4. PubMed ID: 18496495
[No Abstract] [Full Text] [Related]
7. Magnetic resonance imaging of bone marrow in hairy cell leukemia: correlation with clinical response to alpha-interferon.
Thompson JA; Shields AF; Porter BA; Olson DO; Rubin E; Kidd P; Fefer A
Leukemia; 1987 Apr; 1(4):315-6. PubMed ID: 3669752
[TBL] [Abstract][Full Text] [Related]
8. Multifocal osteolytic lesions in hairy cell leukemia-the importance of PET/CT in diagnosis and assessment.
Robak P; Jesionek-Kupnicka D; Kupnicki P; Polliack A; Robak T
Ann Hematol; 2021 Jun; 100(6):1641-1645. PubMed ID: 32533250
[No Abstract] [Full Text] [Related]
9. Hairy cell leukemia presenting as localized skeletal involvement.
Lal A; Tallman MS; Soble MB; Golubovich I; Peterson L
Leuk Lymphoma; 2002 Nov; 43(11):2207-11. PubMed ID: 12533048
[TBL] [Abstract][Full Text] [Related]
10. Review: isolated skeletal involvement in hairy cell leukemia.
Hamadani M; Kraut EH
Clin Adv Hematol Oncol; 2008 Apr; 6(4):294-6. PubMed ID: 18496496
[No Abstract] [Full Text] [Related]
11. Potential breakthroughs with investigational drugs for hairy cell leukemia.
Robak T; Wolska A; Robak P
Expert Opin Investig Drugs; 2015; 24(11):1419-31. PubMed ID: 26329588
[TBL] [Abstract][Full Text] [Related]
12. Bone involvement in hairy cell leukemia.
Quesada JR; Keating MJ; Libshitz HI; Llamas L
Am J Med; 1983 Feb; 74(2):228-31. PubMed ID: 6824003
[TBL] [Abstract][Full Text] [Related]
13. [Hairy cell leukemia complicated by bone marrow necrosis following cladribine administration].
Terao T; Yuda J; Yamauchi N; Miyamoto K; Minami M; Kojima M; Sugano M; Kuwata T; Minami Y
Rinsho Ketsueki; 2019; 60(6):559-564. PubMed ID: 31281144
[TBL] [Abstract][Full Text] [Related]
14. Biology and Treatment of Hairy Cell Leukemia.
Paillassa J; Troussard X
Curr Treat Options Oncol; 2020 Apr; 21(6):44. PubMed ID: 32350628
[TBL] [Abstract][Full Text] [Related]
15. Unusual presentation of hairy cell leukemia.
Spedini P; Tajana M; Bergonzi C
Haematologica; 2000 May; 85(5):548. PubMed ID: 10800175
[No Abstract] [Full Text] [Related]
16. Bone marrow in hairy cell leukemia.
Katayama I
Hematol Oncol Clin North Am; 1988 Dec; 2(4):585-602. PubMed ID: 3065320
[TBL] [Abstract][Full Text] [Related]
17. Bone marrow infiltration in hairy cell leukemia after interferon therapy detected by magnetic resonance imaging.
Silingardi V; Davolio-Marani S; Federico M; Piccinini L; Frassoldati A; Sarti M; Burani A; Canossi G
Eur J Cancer Clin Oncol; 1989 Feb; 25(2):209-13. PubMed ID: 2702977
[TBL] [Abstract][Full Text] [Related]
18. Selective myeloid aplasia: a long-lasting presentation of an unusual hairy cell leukemia variant?
Marinone GM; Roncoli B
Haematologica; 1993; 78(4):239-41. PubMed ID: 8294056
[TBL] [Abstract][Full Text] [Related]
19. Hairy-cell leukemia presenting as lytic bone lesions.
Gray MT; Rutherford MN; Bonin DM; Patterson B; Lopez PG
J Clin Oncol; 2013 Sep; 31(25):e410-2. PubMed ID: 23797001
[No Abstract] [Full Text] [Related]
20. Moxetumomab pasudotox for the treatment of hairy cell leukemia.
Janus A; Robak T
Expert Opin Biol Ther; 2019 Jun; 19(6):501-508. PubMed ID: 31045462
[No Abstract] [Full Text] [Related]
[Next] [New Search]
